The State of Oncology in 2026 With ZS
FDA Fast Track Designation: BiPASS for Pre-Biopsy PSMA-PET Imaging in Prostate Cancer
MiNK Therapeutics Selected for ARPA-H Initiative to Develop Room-Temperature Cell Therapy
Joe Y Chang։ I-SABR Phase II Study Shows Improved Overall Survival With Immunotherapy Added to SABR in Early-Stage NSCLC
Vivek Subbiah: Tumour-Agnostic Immunotherapy Brings a New Dimension to Precision Oncology
Amitabh Ray at COGC 2026: Low-Tech, High-Trust Solutions for Community Oncology
Hellenic Cancer Federation | ELLOK Brings Greece Into the EU Cancer Mission
